CLINICAL_TRIALS
trial_result
· 2020-12-02
Clinical Trial Update: Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Summary
Post-market registry update for the CorPath 200 system in percutaneous coronary interventions; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Corindus Inc. | Conditions: Coronary Artery Disease, Coronary Disease | Status: COMPLETED | Results posted: 2020-12-02